Detalles
This document provides additional guidance in the pharmaceutical and biotechnology sector. This covers: The assessment of nature-related issues using the TNFD's LEAP approach and the disclosure of sector-specific metrics in line with the approach recommended by the TNFD.
Recursos relacionados
Frequently Asked Questions (FAQ) on the implementation of the EUDR Regulation
Many countries around the world have made significant efforts over the past decade to reduce deforestation, for example by introducing…
2022
Where is corporate reporting heading?
El documento recoge las principales tendencias en la comunicación ambiental, social y de gobernanza y su conexión con la información…
Biodiversity Data is it fit to purpose?
Momentum to tackle biodiversity loss is building, with nearly 200 countries at COP15 in Montreal pledging to halt and reverse…